"Advancements in MS Diagnosis, NB-4746, and Neubie Stimulation Unveiled in MS News Notes"

Diagnosing primary progressive MS (PPMS) remains challenging despite guidelines, as a study in the Netherlands found that only 228 out of 322 people diagnosed with PPMS actually met the criteria. Additionally, clinical testing has begun for an investigational treatment that aims to block an enzyme contributing to nerve damage in MS patients, and an electronic device called Neubie has been found to improve strength and mobility in people with MS when used as an add-on to physical therapy.